Nobel laureate Carolyn Bertozzi joins cell therapy biotech Acepodia as chief scientific advisor

Nicole DeFeudis

Editor

Carolyn Bertozzi helped kindle the spark that became cell therapy biotech Acepodia while the company’s co-founder, Sonny Hsiao, was still a PhD student, working in …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Nobel laureate Carolyn Bertozzi joins cell therapy biotech Acepodia as chief scientific advisor

Nicole DeFeudis

Editor

Sign up to read this article for free.

Global Head of Marketing

Bachem

Bubendorf, BL, Switzerland

First meeting of CDC vaccine advisors in the Kennedy era is postponed

How Keymed steered the China-to-US NewCo model in biotech

In single case, spinal muscular atrophy drug given before birth spared baby of genetic disease symptoms

Roche no longer wants to be where ‘DNA sequencing goes to die’

Trump’s HHS defends drug price negotiations in Novartis suit

Trusted protection: Why the current meningococcal vaccination schedule shouldn’t change without strong evidence

No­bel lau­re­ate Car­olyn Bertozzi joins cell ther­a­py biotech Ace­po­dia as chief sci­en­tif­ic ad­vi­sor

Editor

Sign up to read this article for free.

Bachem

Bubendorf, BL, Switzerland

Nobel laureate Carolyn Bertozzi joins cell therapy biotech Acepodia as chief scientific advisor